Catalyst Wire Dossier Catalyst Wire Dossier

Ivermectin 18 mg fixed-dose tablet

Ivermectin · LICONSA S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ivermectin 18 mg fixed-dose tablet, covering 2017-06-02 to 2017-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil) [Phase 1]

See pricing